Stakeholders have four weeks to respond

EC launches EU health claims ‘fitness check’; nutrient profiles and botanicals targeted

EC launches EU health claims ‘fitness check’; nutrient profiles and botanicals targeted

The European Commission has launched a ‘fitness check/roadmap’ with a special focus on the EU’s botanical health claims imbroglio and the nutrient profile of foods able to bear health claims. Both issues remain unresolved under EU health claim laws introduced in July 2007.

Stakeholders have four weeks to give input into the roadmap which avoids a broader assessment of the controversial regulation given that the list of authorised health claims only came into application in December 2012.” Such a roadmap may come later.

Eight years after the EU nutrition and health claims regulation (NHCR) was written into law the EC wants to discover whether it is “fit for purpose” and achieved “its overall objectives on truthful information to consumers and the facilitation of the free movement of foods bearing claims.”

It would seek to determine whether much-debated nutrient profile models "warranted and adequate to ensure the objectives of the Regulation".

Five criteria will drive the assessment:

  • Effectiveness
  • Efficiency
  • Relevance
  • Coherence
  • EU added value

Botanicals under the microscope

The European Federation of Associations of Health Product Manufacturers (EHPM) welcomed the EC move, especially in regard to the EU’s €2bn botanicals market (of €9bn for food supplements in total).

Under the NHCR there are about 1500 botanical health claim submission on-hold since 2011. Before then about 500 were rejected by the European Food Safety Authority (EFSA).

“EHPM thinks that this is a very positive development and we hope it can lead to the development of a workable regulatory structure for botanicals,” said director general Patrick Ahern, noting the group had already sent its policy priorities to the EC.

These included an acknowledgement nutrient-based science should not be treated in the same way as pharma science. “Foods are not drugs and should not be assessed as if they are,” EHPM said in that statement. 

"Numerous health claims have been dismissed by EFSA which were previously approved by national authorities when this area was regulated at national level."

It added: "EHPM urges the Commission to respect national traditions and best practice when formulating an appropriate policy."

The EC roadmap preamble acknowledges that in the case of botanicals there has been much debate over the usability of ‘tradition of use’ data in backing health claims, and noting how such data has been more readily admissible under the Traditional Herbal Medicinal Products Directive (THMPD), which since 2011 has offered a route to market for herbal products in the EU that lies between food and medicines laws.

“Under the legislation on medicinal products for human use, herbal medicinal products may undergo a simplified registration procedure instead of an authorisation procedure on the basis of criteria specified in the legislation on medicinal products for human use such as evidence on medicinal use throughout a period of at least 30 years 'traditional use', the EC report states.

 

Related News

'We would have access to thousands of scientists that usually don’t work with EFSA,' says EFSA boss

New tech on EFSA’s horizon: Crowdsourcing and cyber assistants

Food for Health Ireland’s (FHI), Gelita and Chios Mastiha Growers Association all take a shot at an EFSA health claim. iStock.com / BrianAJackson

EFSA's claim agenda: Joint health, blood sugar, indigestion & stomach ulcers

The Horn File: 'Protecting consumers and creating a workable regulatory framework for the SMEs, such as my own, which make up the majority of our sector are not mutually exclusive goals.' ©iStock

New EHPM chair promises botanicals progress at ‘crucial point for our industry’

©iStock/kamolmek

EU botanicals mini-Q&A

Application of the THMPD differs among EU member states. ©iStock/amnarj2006

THMPD: Has it delivered?

EFSA: “The fact we are here is an indication we are willing to commit to dialogue.”

Open book: The future of probiotic marketing in Europe

Q&A: Industry bodies lay down the law on key European issues

Q&A: Industry bodies lay down the law on key European issues

"As usual science and industry go faster than the regulator..."

Medicinal probiotics need their own legal framework

What degree of evidence is required to make an EU health claim?

What degree of evidence is required to make an EU health claim?

"It could solve the problem for products having clear nutritional benefits in diseased populations..."

EFSA issues medical foods guidance

Creatine and elderly muscle claim considered

EFSA considers health claim for creatine and elderly muscle function

Related Products

See more related products

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.